Product Information
DEXMETHYLPHENIDATE 10 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.3414 per EA under NDC 67877065701. Its NADAC has been published 223 times since Jun 29, 2022.
FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877065701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212631FDA Approved
7/19/2019
TE Code
AB
On Market Since
7/21/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE 10 MG TAB has been published 223 times since Jun 29, 2022, and over the history we have for it it has risen 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3414 per EA |
|---|---|
| All-time high | $0.4149 (Jul 16, 2025) |
| All-time low | $0.2038 (Feb 22, 2023) |
| 52-week high | $0.3791 |
| 52-week low | $0.3297 |
| Median price | $0.3414 |
| Average price | $0.3294 |
| Largest weekly change | -33.9% (Apr 17, 2024) |
| Weeks tracked | 223 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE 10 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.3414 per EA (NDC 67877065701), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE 10 MG TAB has risen 30.9%. It has been tracked across 223 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE 10 MG TAB?
Since Jun 29, 2022, the NADAC for DEXMETHYLPHENIDATE 10 MG TAB has ranged from a low of $0.2038 (Feb 22, 2023) to a high of $0.4149 (Jul 16, 2025), with a median of $0.3414 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE 10 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE 10 MG TAB, is $0.2608 per EA — about 24% below DEXMETHYLPHENIDATE 10 MG TAB.
Who manufactures DEXMETHYLPHENIDATE 10 MG TAB?
DEXMETHYLPHENIDATE 10 MG TAB (NDC 67877065701) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.